Latest news
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? - StocktwitsStocktwits · Sat, 08 Aug 2026 18:22:11 GMTNovo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50% - StocktwitsStocktwits · Sat, 08 Aug 2026 14:00:57 GMTHIMS Stock Crashes Overnight After Brutal Q1 — But An Investor Says Novo, Lilly Deals Could Make It ‘Netflix Of Healthcare’ - StocktwitsStocktwits · Sat, 08 Aug 2026 11:11:32 GMTTD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - StocktwitsStocktwits · Sat, 08 Aug 2026 06:08:41 GMTLLY Vs. NVO: Whose Oral Obesity Drug Had Better Launch Reception? - StocktwitsStocktwits · Sat, 08 Aug 2026 02:14:25 GMTLLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials - StocktwitsStocktwits · Fri, 07 Aug 2026 22:33:00 GMTNovo Nordisk To Meet Wegovy Pill Demand In US Before Expanding To Avoid Supply Shortage, Says CEO Doustdar - StocktwitsStocktwits · Fri, 07 Aug 2026 17:16:04 GMTNovo's 'Flashy' Ozempic, Wegovy Price Cuts Unlikely To Impact LLY Stock, Says BofA - StocktwitsStocktwits · Fri, 07 Aug 2026 11:05:21 GMT